UniProt ID | SP2_HUMAN | |
---|---|---|
UniProt AC | Q02086 | |
Protein Name | Transcription factor Sp2 | |
Gene Name | SP2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 613 | |
Subcellular Localization | Nucleus. | |
Protein Description | Binds to GC box promoters elements and selectively activates mRNA synthesis from genes that contain functional recognition sites.. | |
Protein Sequence | MSDPQTSMAATAAVSPSDYLQPAASTTQDSQPSPLALLAATCSKIGPPAVEAAVTPPAPPQPTPRKLVPIKPAPLPLSPGKNSFGILSSKGNILQIQGSQLSASYPGGQLVFAIQNPTMINKGTRSNANIQYQAVPQIQASNSQTIQVQPNLTNQIQIIPGTNQAIITPSPSSHKPVPIKPAPIQKSSTTTTPVQSGANVVKLTGGGGNVTLTLPVNNLVNASDTGAPTQLLTESPPTPLSKTNKKARKKSLPASQPPVAVAEQVETVLIETTADNIIQAGNNLLIVQSPGGGQPAVVQQVQVVPPKAEQQQVVQIPQQALRVVQAASATLPTVPQKPSQNFQIQAAEPTPTQVYIRTPSGEVQTVLVQDSPPATAAATSNTTCSSPASRAPHLSGTSKKHSAAILRKERPLPKIAPAGSIISLNAAQLAAAAQAMQTININGVQVQGVPVTITNTGGQQQLTVQNVSGNNLTISGLSPTQIQLQMEQALAGETQPGEKRRRMACTCPNCKDGEKRSGEQGKKKHVCHIPDCGKTFRKTSLLRAHVRLHTGERPFVCNWFFCGKRFTRSDELQRHARTHTGDKRFECAQCQKRFMRSDHLTKHYKTHLVTKNL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
8 (in isoform 2) | Phosphorylation | - | 3.14 | 29116813 | |
10 (in isoform 2) | Phosphorylation | - | 6.80 | 29116813 | |
11 | Phosphorylation | PQTSMAATAAVSPSD HHHHHHHCCCCCHHH | 12.95 | 27251275 | |
15 | Phosphorylation | MAATAAVSPSDYLQP HHHCCCCCHHHHCCC | 17.60 | 26552605 | |
17 | Phosphorylation | ATAAVSPSDYLQPAA HCCCCCHHHHCCCCC | 31.23 | 26552605 | |
19 | Phosphorylation | AAVSPSDYLQPAAST CCCCHHHHCCCCCCC | 16.15 | 26552605 | |
25 | Phosphorylation | DYLQPAASTTQDSQP HHCCCCCCCCCCCCC | 33.81 | 27251275 | |
26 | Phosphorylation | YLQPAASTTQDSQPS HCCCCCCCCCCCCCC | 24.61 | 27251275 | |
27 | Phosphorylation | LQPAASTTQDSQPSP CCCCCCCCCCCCCCH | 28.08 | 26552605 | |
30 | Phosphorylation | AASTTQDSQPSPLAL CCCCCCCCCCCHHHH | 33.89 | 26552605 | |
33 | Phosphorylation | TTQDSQPSPLALLAA CCCCCCCCHHHHHHH | 25.55 | 32142685 | |
41 | Phosphorylation | PLALLAATCSKIGPP HHHHHHHHHHHHCCC | 16.23 | 26552605 | |
43 | Phosphorylation | ALLAATCSKIGPPAV HHHHHHHHHHCCCCE | 23.97 | 26552605 | |
55 | Phosphorylation | PAVEAAVTPPAPPQP CCEEECCCCCCCCCC | 20.87 | 29255136 | |
63 | Phosphorylation | PPAPPQPTPRKLVPI CCCCCCCCCCCCEEC | 30.40 | 29255136 | |
78 | Phosphorylation | KPAPLPLSPGKNSFG CCCCCCCCCCCCCEE | 29.66 | 29255136 | |
83 | Phosphorylation | PLSPGKNSFGILSSK CCCCCCCCEEEECCC | 28.47 | 29978859 | |
88 | Phosphorylation | KNSFGILSSKGNILQ CCCEEEECCCCCEEE | 28.25 | 23312004 | |
89 | Phosphorylation | NSFGILSSKGNILQI CCEEEECCCCCEEEE | 40.93 | 23312004 | |
102 | Phosphorylation | QIQGSQLSASYPGGQ EEECCEEEEECCCCE | 13.92 | 27251275 | |
104 | Phosphorylation | QGSQLSASYPGGQLV ECCEEEEECCCCEEE | 28.60 | 27251275 | |
187 | Phosphorylation | KPAPIQKSSTTTTPV CCCCCCCCCCCCCCC | 19.28 | 25159151 | |
187 | O-linked_Glycosylation | KPAPIQKSSTTTTPV CCCCCCCCCCCCCCC | 19.28 | 30059200 | |
188 | Phosphorylation | PAPIQKSSTTTTPVQ CCCCCCCCCCCCCCC | 36.49 | 25159151 | |
188 | O-linked_Glycosylation | PAPIQKSSTTTTPVQ CCCCCCCCCCCCCCC | 36.49 | 30059200 | |
189 | Phosphorylation | APIQKSSTTTTPVQS CCCCCCCCCCCCCCC | 34.94 | 25159151 | |
190 | Phosphorylation | PIQKSSTTTTPVQSG CCCCCCCCCCCCCCC | 30.53 | 27732954 | |
191 | Phosphorylation | IQKSSTTTTPVQSGA CCCCCCCCCCCCCCC | 29.23 | 25159151 | |
192 | Phosphorylation | QKSSTTTTPVQSGAN CCCCCCCCCCCCCCE | 21.26 | 25159151 | |
196 | Phosphorylation | TTTTPVQSGANVVKL CCCCCCCCCCEEEEE | 39.86 | 29396449 | |
196 | O-linked_Glycosylation | TTTTPVQSGANVVKL CCCCCCCCCCEEEEE | 39.86 | 30059200 | |
223 | Phosphorylation | VNNLVNASDTGAPTQ CCCEECCCCCCCCCH | 30.42 | 28348404 | |
225 | Phosphorylation | NLVNASDTGAPTQLL CEECCCCCCCCCHHH | 32.52 | 28348404 | |
229 | Phosphorylation | ASDTGAPTQLLTESP CCCCCCCCHHHCCCC | 31.17 | 28122231 | |
233 | Phosphorylation | GAPTQLLTESPPTPL CCCCHHHCCCCCCCC | 42.90 | 28122231 | |
235 | Phosphorylation | PTQLLTESPPTPLSK CCHHHCCCCCCCCCC | 30.83 | 22199227 | |
238 | Phosphorylation | LLTESPPTPLSKTNK HHCCCCCCCCCCCCH | 40.00 | 22199227 | |
241 | Phosphorylation | ESPPTPLSKTNKKAR CCCCCCCCCCCHHHH | 38.34 | 22199227 | |
358 | Phosphorylation | PTQVYIRTPSGEVQT CCEEEEECCCCCEEE | 16.55 | 27251275 | |
360 | Phosphorylation | QVYIRTPSGEVQTVL EEEEECCCCCEEEEE | 47.15 | 27251275 | |
365 | Phosphorylation | TPSGEVQTVLVQDSP CCCCCEEEEEEECCC | 22.45 | 27251275 | |
371 | Phosphorylation | QTVLVQDSPPATAAA EEEEEECCCCCCEEC | 18.72 | 28464451 | |
375 | Phosphorylation | VQDSPPATAAATSNT EECCCCCCEECCCCC | 23.70 | 27251275 | |
379 | Phosphorylation | PPATAAATSNTTCSS CCCCEECCCCCCCCC | 20.13 | 27251275 | |
380 | Phosphorylation | PATAAATSNTTCSSP CCCEECCCCCCCCCC | 27.70 | 27251275 | |
382 | Phosphorylation | TAAATSNTTCSSPAS CEECCCCCCCCCCCC | 29.01 | 27251275 | |
383 | Phosphorylation | AAATSNTTCSSPASR EECCCCCCCCCCCCC | 18.03 | 27251275 | |
385 | Phosphorylation | ATSNTTCSSPASRAP CCCCCCCCCCCCCCC | 36.95 | 27251275 | |
386 | Phosphorylation | TSNTTCSSPASRAPH CCCCCCCCCCCCCCC | 26.99 | 30576142 | |
389 | Phosphorylation | TTCSSPASRAPHLSG CCCCCCCCCCCCCCC | 32.15 | 27251275 | |
395 | Phosphorylation | ASRAPHLSGTSKKHS CCCCCCCCCCCCCHH | 36.67 | 26657352 | |
397 | Phosphorylation | RAPHLSGTSKKHSAA CCCCCCCCCCCHHHH | 33.72 | 25262027 | |
398 | Phosphorylation | APHLSGTSKKHSAAI CCCCCCCCCCHHHHH | 43.14 | 25262027 | |
400 | Ubiquitination | HLSGTSKKHSAAILR CCCCCCCCHHHHHHH | 42.43 | 29967540 | |
535 | Phosphorylation | HIPDCGKTFRKTSLL ECCCCCCCHHHHHHH | 17.60 | - | |
540 | Phosphorylation | GKTFRKTSLLRAHVR CCCHHHHHHHHHEEE | 28.57 | 24719451 | |
550 | Phosphorylation | RAHVRLHTGERPFVC HHEEEECCCCCCEEE | 45.38 | 18669648 | |
567 | Phosphorylation | FFCGKRFTRSDELQR EEECCCCCCCHHHHH | 33.04 | 30108239 | |
569 | Phosphorylation | CGKRFTRSDELQRHA ECCCCCCCHHHHHHH | 32.17 | 29496963 | |
578 | Phosphorylation | ELQRHARTHTGDKRF HHHHHHHHCCCCCHH | 25.27 | 28450419 | |
605 | Ubiquitination | DHLTKHYKTHLVTKN HHHHHHHHHHEEECC | 29.23 | 29967540 | |
610 | Phosphorylation | HYKTHLVTKNL---- HHHHHEEECCC---- | 22.15 | 24719451 | |
611 | Ubiquitination | YKTHLVTKNL----- HHHHEEECCC----- | 49.09 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SP2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SP2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SP2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NR0B2_HUMAN | NR0B2 | physical | 17071613 | |
NKX31_MOUSE | Nkx3-1 | physical | 16201967 | |
IRF1_HUMAN | IRF1 | physical | 19482358 | |
A4_HUMAN | APP | physical | 21832049 | |
BANP_HUMAN | BANP | physical | 25416956 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-192, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-550, AND MASSSPECTROMETRY. |